Search

Background/objectivesWe provide global averages and standard deviations for ocular biometry-axial length (AL), corneal radius of curvature (CR), anterior chamber depth (ACD), lens thickness (LT), white to white (WTW), and central corneal thickness (CT). We hope a better understanding of normal and abnormal values will help clinicians gain further insight into their surgical outcomes, especially for off-target eyes.Subjects/methodsWe searched the MEDLINE database using keywords "axial length, corneal power, anterior chamber depth, lens thickness, white to white, and corneal thickness." We included studies that reported averages and standard deviations on eye biometry for at least 1300 eyes. Global weighted averages and standard deviations were calculated using the Cochrane method.ResultsFourteen studies were included, originating from Asia (Japan, Singapore, Myanmar, Iran, South Korea, China), Europe (Germany, United Kingdom, Portugal), Australia, and North America (United States). Global ocular biometry metrics were: AL-23.49 mm ± 1.35 mm, CR-7.69 mm ± 0.28 mm, ACD-3.10 mm ± 0.47 mm, WTW-11.80 mm ± 0.42 mm, LT-4.37 mm ± 0.43 mm, and CT-544 μm ± 38 μm. Total eyes per value ranged from 19,538 to 90,814.ConclusionsWe report global ocular biometry averages and standard deviations. No eyes were from studies in Africa or South America, highlighting the need to publish eye biometry data from these continents. We hope that promoting a deeper understanding of biometry values will help clinicians gain insight into surgical outcomes and drive innovations in lens calculations.

We report a case of a child with secondary open-angle glaucoma who developed 6.5 diopters (D) of corneal flattening upon the addition of Rhopressa (0.02% netarsudil dimesylate solution) eye drops to a preexisting treatment regimen of timolol and latanoprost. This change in corneal power reversed after netarsudil, a rho-kinase inhibitor, was discontinued and replaced with Vyzulta (0.024% latanoprostene bunod ophthalmic solution). The 4-year-old female patient presented with bilateral secondary open-angle glaucoma from Paired Box 6 (PAX6)-related aniridia, aphakia, and persistent fetal vasculature. She was started on netarsudil to treat elevated intraocular pressure (IOP) in her right eye, which was not adequately controlled by latanoprost and timolol. Over 4 months, she developed 6.5D of corneal flattening in her right eye. Netarsudil was stopped and the corneal flattening reversed. There is evidence to support the ability of rho kinase inhibitors to increase the healing of the corneal endothelium in addition to their intended IOP-lowering effects. Rho kinase inhibitors may increase cell proliferation and adhesion within the corneal endothelium, hence decreasing apoptosis and promoting cell preservation. If there was an excess of cell proliferation; however, this might induce stromal cells to abnormally secrete enzymes or proteins, such as TGFβ-induced proteins. This could result in corneal fibrosis, thereby flattening the cornea. Further investigation is required to explore this phenomenon and elucidate its mechanism of action. Corneal flattening may be considered as a potential side effect of the use of netarsudil, particularly in young pediatric patients.

Purpose: To describe the outcomes from treatment of macular neovascularization in an eye affected by late-onset retinal degeneration. Methods: A 72-year-old female patient presented with a history of decreased vision since several years. The patient was previously diagnosed with age-related macular degeneration and treated with anti-vascular endothelial growth factors. Results: Clinical examination of the retina and ultra-widefield color fundus photographs showed extensive atrophy in both eyes. The left eye showed macular neovascularization on fluorescein angiography, subretinal fluid on optical coherence tomography, and correspondent hemorrhages on the color fundus photography. Aflibercept anti-vascular endothelial factor treatment was used to treat the macular neovascularization in the left eye. Conclusion: We report a case of genetically confirmed late-onset retinal degeneration (heterozygous pathogenic mutation p.Ser163Arg in one C1QTN5 allele) with advanced degeneration of the retina complicated by macular neovascularization, which responded well to treatment with a single aflibercept injection. [ABSTRACT FROM AUTHOR]

Fungal infections have a crude mortality rate of 40% among immunocompromised patients, who are very susceptible due to drug resistant yeast strains and delayed diagnosis. In fact, in the United States alone, annual therapeutic treatments cost $2.8 billion. This study aims to develop preventive treatments to complement established infection control for fungal infections. The hypothesis was that the combination of probiotics with cinnamon would be the most effective treatment. Various combinations and concentrations of overthe- counter supplements were evaluated in their ability to inhibit yeast and detrimental bacterial growth while proliferating beneficial bacteria. Saccharomyces, E. coli, and B. megaterium were grown in petri dishes to represent detrimental yeast, beneficial bacteria, and detrimental intestinal bacteria respectively. By measuring the zone of inhibition, this study shows that probiotics recreate an oxygenated, nonacidic, and beneficial bacterial habitat without interfering with the antifungal. The combination of oil of oregano (Origanum syriacum var. bevanii) with acidophilus was the most effective treatment, not supporting the hypothesis. Overall, taking oil of oregano and acidophilus with the antibiotic regimen may reduce the risk of developing fungal infections. Further research into understanding the underlying mechanism of these results and evaluating the clinical implications of this combination is recommended. [ABSTRACT FROM AUTHOR]